FAS system deregulation in T-cell lymphoblastic lymphoma

María Villa‐Morales(Centre for Biomedical Network Research on Rare Diseases), José Fernández‐Piqueras(Centre for Biomedical Network Research on Rare Diseases)

Cell Death and Disease

March 6, 2014

10.1038/cddis.2014.83

Cited by 17

Related Papers

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development

|Leukemia|2015|33

Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development

|Carcinogenesis|2013|29

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

|Carcinogenesis|2019|18

RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas

|BMC Cancer|2018|15

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas , FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

|Carcinogenesis|2010|14